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OBJECTIVES We sought to determine the prevalence and correlates of aortic regurgitation (AR) in a
population-based sample group.
BACKGROUND Concern over induction of AR by weight loss medication highlights the importance of
assessing the prevalence and correlates of AR in unselected patient groups.
METHODS Aortic regurgitation was assessed by color flow Doppler echocardiography in 3,501 American
Indian participants age 47 to 81 years during the second Strong Heart Study.
RESULTS Mild (11) AR was present in 7.3%, 21 AR in 2.4% and 31 to 41 AR in 0.3% of
participants, more frequently in those $60 years old than in those ,60 years old (14.4% vs.
5.8%, p , 0.001); AR was unrelated to gender. Compared with participants without AR,
those with mild AR had a lower body mass index (p , 0.004) and higher systolic pressure
(p , 0.003). Participants with AR had larger aortic root diameters (3.6 6 0.4 vs. 3.4 6
0.4 cm, p , 0.001), higher creatinine levels (1.3 6 1.3 vs. 1.0 6 1.0 mg/dl, p , 0.001) and
higher urine albumin/creatinine levels (3.6 6 2.3 vs. 3.3 6 2.0 log, p , 0.001), as well as
higher prevalences of aortic stenosis (AS) or mitral stenosis (MS) (p , 0.001). Regression
analysis showed that AR was independently related to older age and larger aortic roots (p ,
0.0001), AS and absence of diabetes (p 5 0.002), MS (p 5 0.003) and higher log urine
albumin/creatinine (p 5 0.005).
CONCLUSIONS Aortic regurgitation occurred in 10% of a sample group of middle-aged to older adults and
was related to older age, larger aortic root diameter, aortic and mitral stenosis and
albuminuria. There was no association of AR with being overweight and a negative
association of AR with diabetes. (J Am Coll Cardiol 2000;36:461–7) © 2000 by the
American College of Cardiology
With improving technology and increasing use of Doppler
echocardiography in recent years, detection and character-
ization of regurgitant valvular heart disease have been
facilitated. Doppler echocardiography has been used to
derive estimates of the prevalence of valvular regurgitation
in small, selected groups, composed primarily of normal
volunteers (1–6). Other studies evaluated whether the
prevalence of valvular regurgitation was related to age in
small groups of apparently normal subjects (7,8). However,
most of these studies predated the use of color Doppler
echocardiography, which has increased the accuracy and
sensitivity for the detection of valvular regurgitation. A
recent study examined the prevalence of valvular regurgita-
tion in unselected young adults (Reid JL, Gardin J, Yunis C,
personal communication), and data have been provided, by
the Framingham Heart Study (9) regarding the prevalence
of regurgitation in adults of a wide age range.
With the recent concern over the induction of valvular
heart disease by popular prescription appetite-suppressant
medications, and their subsequent withdrawal from the
market, there has been debate and uncertainty over the true
prevalence of regurgitant valvular heart disease and its
relation to obesity in the general adult population (10–14).
We therefore undertook this study to assess the prevalence
and correlates of aortic valve regurgitation using color
Doppler echocardiography in a large, adult population that
included a high proportion of overweight individuals.
METHODS
As previously described, the Strong Heart Study (SHS) is
an epidemiologic survey of cardiovascular risk factors and
prevalent and incident cardiovascular disease in 13 Ameri-
can Indian tribes in Arizona, Oklahoma, South Dakota and
North Dakota (15–17). At enrollment, the study cohort
included adult members age 45 to 74 years in three tribes in
central Arizona, seven tribes in Oklahoma and three tribes
From the Department of Medicine, The New York Hospital–Cornell Medical
Center, New York, New York; *School of Public Health, University of Oklahoma
Health Sciences Center, Oklahoma City, Oklahoma; †National Heart Lung and
Blood Institute, Bethesda, Maryland; ‡Aberdeen Area Tribal Chairman’s Health
Board, Rapid City, South Dakota; and §Medlantic Research Institute, Washington,
DC. This study was supported in part by cooperative agreement grants U01-
HL41642, U01-HL41652 and U01-HL41654 from the National Heart, Lung, and
Blood Institute, National Institutes of Health, Bethesda, Maryland, and grant
M10RR0047-34 (GCRC) from the National Institutes of Health. The views
expressed in this report are those of the authors and do not necessarily reflect those of
the Indian Health Service.
Manuscript received December 9, 1998; revised manuscript received January 28,
2000, accepted March 30, 2000.
Journal of the American College of Cardiology Vol. 36, No. 2, 2000
© 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00
Published by Elsevier Science Inc. PII S0735-1097(00)00744-0
in North and South Dakota, recruited from defined sam-
pling frames of eligible individuals (overall participation rate
61%) and initially examined between July 1989 and January
1992. Characterization of subjects included a medical his-
tory, electrocardiogram (ECG) and measurement of bra-
chial and ankle blood pressure; aspects of body habitus
included body mass index and waist/hip ratio. Fat-free mass
and adipose body mass were estimated using an RJL
impedance meter (model B14101; RJL Equipment Com-
pany, Detroit, Michigan). Fasting glucose, glycosylated
hemoglobin, insulin, lipid and lipoprotein levels were ob-
tained, and a 2-h glucose tolerance test was performed as
previously described (15). A total of 3,637 SHS cohort
members (89% of those still alive) returned for the second
SHS examination from August 1993 to December 1995, to
assess changes over time in baseline measures and to
perform echocardiography, pulmonary function tests and
gall bladder imaging. Participants were classified as hyper-
tensive if their rest blood pressure was $140 mm Hg
systolic or $90 mm Hg diastolic, or if they were taking
antihypertensive medications (18,19). Participants gave
written, informed consent under protocols approved by
tribal and Indian Health Service Institutional Review
Boards.
Echocardiographic methods. Studies were performed us-
ing Acuson 128 (Acuson, Inc., Mountain View, California)
phased-array echocardiography with M-mode, two-
dimensional and pulsed, continuous wave and color flow
Doppler modalities (20,21). Examination tables with apical
cut-outs were used with the head of the table elevated
;30°C in a partial decubitus position. The parasternal
acoustic window was used to record $10 consecutive beats
of two-dimensional and M-mode recording of the left
ventricular (LV) internal diameter and wall thickness at or
just below the tips of the mitral valve leaflets in long- and
short-axis LV views and long-axis views of the mitral valve.
M-mode and two-dimensional short- and long-axis views
of the aortic root and left atrium were also obtained. The
apical acoustic window was employed to record $10 cycles
of two- and four-chamber recordings to assess LV wall
motion.
Color flow Doppler recordings from the parasternal and
apical windows were used to search for aortic and mitral
regurgitation (22). Aortic regurgitation (AR) was identified
according to the extent of diastolic turbulent flow in the LV,
indicated by a variance signal, with mild (11) AR identified
by a jet occupying ,20% of the aortic annular diameter at
its origin and extending less than half way to the tip of the
anterior mitral leaflet; moderate (21) AR by jets filling 20%
to 40% of the annular diameter extending up to the tip of
the anterior mitral leaflet; moderately severe (31) AR by
jets occupying 40% to 60% of the annular diameter extend-
ing to or slightly beyond the tip of the anterior mitral leaflet;
and severe (41) AR by jets occupying .60% of the annular
diameter extending to the posterior wall of the LV or more
than half way to the LV apex. For jets oriented perpendic-
ular to the aortic annular plane, rather than crossing the
valve’s LV surface, priority was given to jet length criteria.
Recordings were made entirely on videotape. Concomitant
mitral regurgitation was assessed by color Doppler criteria
according to regurgitant jet area and depth (22).
Echocardiographic measurements. Preliminary measure-
ments were made at the Reading Center in New York by an
experienced sonography reader (M.P.) and verified, with
corrections when necessary, by a physician investigator
(R.B.D. or M.J.R.). Correct orientation of planes for
imaging and Doppler recording was verified as previously
described (23). Measurements were made using a comput-
erized review station equipped with digitizing tablet and
monitor screen overlay. Left ventricular internal dimension
and interventricular septal and posterior wall thickness were
made at end diastole and end systole on up to three cycles,
according to American Society of Echocardiography (ASE)
recommendations (24). When optimal LV orientation
could not be obtained, as is common in subjects who are
overweight or .60 years old, correctly oriented two-
dimensional linear dimensions were made by the ASE
leading-edge convention (25). Aortic annular dimension
was measured between the hinging points of the aortic valve
leaflets in the parasternal or apical long-axis view that
revealed the largest aortic annular diameter. Diameters of
the aortic annulus and aortic root at the sinuses of Valsalva
were measured in the long-axis view that maximized these
dimensions (26). Aortic annular diameter was measured
from the trailing edge to the leading edge at the hinging
points of the aortic cusps to the annulus, using color flow
mapping to help delineate tissue–blood interfaces, when
necessary; aortic root dimensions were measured using the
leading-edge convention (26). The presence of bicuspid
aortic valves was determined by visualization of the valve in
short-axis views. Aortic stenosis (AS) was identified by
detection of moderately or severely reduced aortic cusp
motion and graded as moderate if the valve area by the
continuity equation (using additional continuous wave re-
cordings) was 0.45 to 0.8 cm2/m2, and severe if it was
smaller.
Data handling and statistical analyses. Data are reported
as the mean value 6 SD for continuous variables and
proportions for categoric variables. Data management and
analysis were performed using a microcomputer equipped
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with SPSS 7.5 software (SPSS, Chicago, Illinois). The
prevalence of AR between groups delineated by gender,
decade of age, presence of diabetes and hypertension was
assessed by the chi-square test. Differences in clinical
variables among participants with and without AR were
assessed by one-way analysis of variance, followed by the
REGWF post-hoc test (27). Independence of an associa-
tion of other variables with AR was assessed by logistic and
linear regression analyses. Two-tailed p , 0.05 was consid-
ered statistically significant.
RESULTS
A total of 3,501 SHS participants (97% of those attending
the second examination) had echocardiograms (1,316 men
and 2,185 women, age range 46 to 82 years [mean 60 6 8]).
Arterial blood pressure was 130 6 21/75 6 10 mm Hg;
1,671 (46%) had hypertension according to the fifth report
of the Joint National Committee on detection, evaluation
and treatment of high blood pressure (JNC-V) criteria (21).
Body mass index was 31.2 6 6.5 kg/m2; 29% had normal
body weight, 17% were overweight and 53% were obese by
National Institutes of Health Consensus Conference criteria
(28). Diabetes mellitus was present, according to World
Health Organization criteria (29), in 1,811 participants
(52%).
Prevalence of AR. Mild (11) AR was found in 257
participants (7.3%)—97 1,316 (7.4%) of 1,316 men and 160
(7.3%) of 2,185 women (p 5 NS). Moderate to severe
($21) AR was found in 93 subjects (2.7%), including 38
men (3.0%) and 55 women (2.5%; p 5 NS). As Figure 1
demonstrates, the prevalence of mild AR increased stepwise
from 4.5% in subjects ,50 years old to 16.4% in those 70 to
79 years old; the corresponding increase in the prevalence of
moderate to severe AR was from 1.6% to 4.5% (p , 0.002).
The overall prevalence of AR was slightly lower in partici-
pants with diabetes (8.7%) than in those with normal
glucose tolerance (10.6%) or impaired glucose tolerance
(glucose levels of 140 to 200 mg/dl 2 h after a 75-g glucose
load) (11.3%; overall p , 0.05). There was no difference in
the prevalence of AR between obese and nonobese partici-
pants (9.2% vs. 11.1%, p 5 0.15). Participants in the three
SHS regions had similar prevalences of mild AR (6.7% to
8.1%) and $21 AR (1.9% to 2.7%) (p 5 NS).
Clinical variables. Table 1 shows clinical and demographic
variables in SHS participants stratified by severity of AR.
The presence of AR was associated with a lower body mass
index, by ;1 kg/m2, in both subgroups with AR. This was
because of lower adipose body mass in participants with AR,
with no intergroup difference in fat-free mass or height.
There was no difference in the change in weight from the
first to the second SHS examination between participants
with no AR (mean 20.3 6 7.5 kg) and those with mild
(11) AR (mean 20.9 6 0.6 kg) or $21 AR (mean 20.9 6
5.5 kg) (overall p 5 0.28). The intergroup difference in body
mass index, but not in weight change, was confirmed in an
additional analysis (data not shown) that excluded individ-
uals with specific causes of AR.
Systolic blood pressure was higher in participants with
AR than in those with no AR. Diastolic blood pressure was
lower in those with $21 AR than in those without AR, but
did not differ between individuals with no AR and those
with 11 AR. Pulse pressure increased stepwise from par-
ticipants with no AR to those with $21 AR (p 5 0.01 after
adjusting for age). No difference existed among groups
Figure 1. The prevalences of both mild (11) AR (solid bars) and more
severe ($21) AR (open bars) in Strong Heart Study participants show
strong positive correlations to increasing age (p , 0.001).
Table 1. Characteristics of Strong Heart Study Participants Classified by the Presence and
Degree of AR
No AR 11 AR >21 AR p Value*
Age (yrs) 60 6 8 64 6 8 63 6 8 , 0.001
Male 37.6% 38.3% 41.7% 0.795
Weight (kg) 84.6 6 18.7 80.3 6 16.0 81.6 6 16.6 0.001
Height (cm) 164.3 6 8.9 163.2 6 8.7 163.3 6 8.9 0.123
Systolic BP (mm Hg) 129.7 6 20.4 133.2 6 20.8 134.5 6 22.0 0.003
Diastolic BP (mm Hg) 75.0 6 10.2 75.4 6 11.8 72.1 6 9.5 0.021
Pulse pressure (mm Hg) 54.7 6 17.2 57.7 6 17.2 62.4 6 20.0 , 0.001
BMI (kg/m2) 31.3 6 6.5 30.1 6 5.8 30.6 6 5.9 0.012
Fat-free mass (kg) 52.9 6 11.5 51.4 6 10.2 53.6 6 11.1 0.119
Adipose mass (kg) 31.7 6 12.5 29.1 6 11.1 28.7 6 11.3 0.001
Ankle/arm index 1.14 6 0.16 1.14 6 0.14 1.13 6 0.14 0.399
Stroke index/pulse pressure
(ml/mm Hg per m2)
0.39 6 0.10 0.41 6 0.15 0.44 6 0.11 , 0.001
*By analysis of variance. Data are presented as the mean value 6 SD, except for male gender.
AR 5 aortic regurgitation; BMI 5 body mass index; BP 5 blood pressure.
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defined by the presence and severity of AR in the ankle/arm
blood pressure index. The stroke index/pulse pressure ratio,
a measure of systemic arterial capacitance, was higher in
individuals with $21 AR.
Laboratory variables (Table 2). In analyses that consid-
ered markers of extracardiac vascular disease, the presence of
AR was associated with higher serum creatinine levels as
well as a higher log of the urine albumin/creatinine ratio.
Lipid values, including total cholesterol, triglycerides and
high and low density lipoproteins did not differ between
groups. Insulin levels were not significantly different be-
tween participants with and those without AR, but fasting
glucose levels were lower in individuals with $21 AR, and
glucose values 2 h after a 75-g glucose load were marginally
lower in those with AR. In addition, glycosylated hemoglo-
bin levels were marginally lower in those with AR than in
those without AR. Fibrinogen levels did not differ between
groups with and without AR.
Potential causes of AR. Aortic root diameter at the level
of the sinuses of Valsalva, as measured on two-dimensional
echocardiography, was larger in both groups with AR
(3.6 6 0.4 cm in each) than in those without AR (mean
3.4 6 0.4 cm, p , 0.001 after adjustment for age). Aortic
stenosis, which was detected in 0.7% of the population, was
more prevalent in the group with AR than in the group
without AR. In fact, as demonstrated in Figure 2, the
prevalence of AR rose from 7.4% among individuals with-
out AS to 45% in those with mild AS and to 100% in those
with moderate or severe AS. The SHS participants with
aortic valve thickening or with a bicuspid aortic valve
(overall prevalence 0.3%) were also more likely to have AR
(Fig. 3, 4). There was also a higher prevalence of AR in
participants with mitral stenosis (MS) (8 [53%] of 15) than
in those without this marker of rheumatic heart disease (342
[10%] of 3,486, p , 0.001). Compared with participants
with no mitral regurgitation, there were higher prevalences
of mild AR and $21 AR in those with mild and $21
mitral regurgitation (5.8% vs. 13.2% and 13.2% and 1.7% vs.
4.5% and 19.7%, respectively; overall p , 0.001). The
prevalence of AR of any degree was slightly higher in SHS
participants with hypertension by JNC-V criteria (11.4%)
than in normotensive individuals (8.8%, p 5 0.02).
Effects of AR on the LV. Analyses of LV status excluded
participants with $21 mitral regurgitation as a potentially
confounding cause of LV volume overload. Left ventricular
internal dimension in diastole increased stepwise with in-
creasing AR (Table 3). Posterior wall and interventricular
septal thicknesses were also greater in subjects with AR than
in those without AR, but did not differ between the group
with mild and the group with moderate to severe AR.
Echocardiographic LV mass and LV mass indexed for
different measures of body size were greater in participants
Figure 2. The prevalences of both mild (11) AR (solid bars) and more
severe ($21) AR (open bars) show progressive increases from individuals
with no AS to those with mild AS to those with moderate or severe AS
(p , 0.001).
Figure 3. The prevalences of both mild (11) AR (solid bars) and more
severe ($21) AR (open bars) were substantially higher (p , 0.001) in
individuals with bicuspid as opposed to trileaflet aortic valves.
Table 2. Laboratory Findings in Strong Heart Study Participants Classified by the Presence and
Degree of AR
No AR 11 AR 21 AR p Value*
Creatinine (mg/dl) 1.0 6 0.9 1.2 6 1.2 1.3 6 1.3 0.001
Urine albumin/creatinine (log) 3.3 6 2.0 3.7 6 2.0 3.6 6 2.3 0.008
Total cholesterol (mg/dl) 190.4 6 40.1 185.1 6 38.3 185.8 6 47.5 0.077
HDL cholesterol (mg/dl) 41.3 6 13.4 41.1 6 13.6 39.7 6 13.3 0.501
LDL cholesterol (mg/dl) 118.5 6 34.3 115.5 6 31.0 116.8 6 39.0 0.385
Triglycerides (mg/dl) 158.8 6 3.7 148.5 6 100.8 149.9 6 108.5 0.287
Insulin (IU) 22.7 6 27.1 19.4 6 15.5 21.1 6 28.7 0.106
Fasting glucose (mg/dl) 155 6 80 146 6 72 135 6 60 0.007
2-h Glucose (mg/dl) 169 6 94 154 6 80 151 6 74 , 0.05
Glycosylated hemoglobin (%) 6.9 6 2.4 6.7 6 2.3 6.4 6 2.1 0.017
Fibrinogen (mg/dl) 364 6 83 366 6 79 365 6 88 0.966
*By analysis of variance. Data are presented as the mean value 6 SD.
AR 5 aortic regurgitation; HDL 5 high density lipoprotein; LDL 5 low density lipoprotein.
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with versus without AR. Further, LV mass increased
stepwise with increasing severity of AR. Relative wall
thickness did not differ between subjects with and without
AR. As a result, the prevalence of eccentric LV hypertrophy
was elevated (37%) in participants with mild AR, especially
in those with at least 21 AR (48%; p , 0.001).
Left ventricular ejection fraction endocardial and mid-
wall fractional shortening were slightly lower in participants
with versus without AR, although there was no difference
between the groups with mild versus moderate to severe AR
(Table 4). Mid-wall fractional shortening was slightly re-
duced in participants with mild AR, but not in individuals
with more severe regurgitation. Circumferential end-
systolic stress showed a stepwise increase with increasing
severity of AR, and as a result, stress-corrected LV mid-wall
shortening—a measure of LV myocardial contractility—did
not differ between the groups. In contrast, the end-systolic
stress/volume index ratio—a measure of LV chamber con-
tractility—showed stepwise decreases with increasing sever-
ity of AR.
Regression analyses. A logistic regression model was de-
veloped in which the presence or absence of AR was related
to the participants’ characteristics (age, body mass index,
presence of hypertension or diabetes) and potential etiolo-
gies (aortic root diameter, AS and MS) as independent
variables (with the addition of gender and height because of
their known relations to other independent variables). Older
age was the strongest correlate of AR, followed by aortic
root diameter (both p , 0.0001), presence of AS and
absence of diabetes (both p 5 0.002), presence of MS (p 5
0.003) and higher log albumin/creatinine ratio (p 5 0.005).
Gender, body mass index, height and hypertension by
JNC-V criteria were not independently related to the
presence of AR. These results were confirmed in a linear
regression analysis in which the grades (0 to 41) of severity
of AR were used as the dependent variable.
DISCUSSION
The present study provides population-based data showing
that AR occurs in ;10% of middle-aged to elderly individ-
uals, in accordance with the only previous epidemiologic
study in this age range (9). In addition, AR increased in
prevalence with advancing age and with the presence of
hypertension, as expected from the limited data previously
available (9,30). Both of these findings are compatible with
damage to the aortic valve occurring gradually over time due
to hemodynamic stress. Regression analyses showed that
AR was independently associated with older age but not
with hypertension when other variables were considered.
Obesity and AR. In contrast to the aforementioned posi-
tive associations, univariate analyses showed a highly signif-
icant and previously unreported negative association be-
tween AR and obesity. the mechanism of this association is
uncertain. Although we did not find an association between
AR and weight loss over the several years before the
echocardiographic study, it is possible that individuals with
AR may have lost weight over a longer period, owing to
either the presence of subtle symptoms or medical advice
after earlier clinical recognition of heart murmur. The fact
that body mass index was not independently associated with
AR in regression analyses raises the possibility that some of
the etiologies of AR that we found to be independently
associated with AR (aortic root enlargement, AS or MS)
could be associated with lower body weight, as previously
observed for mitral valve prolapse, another common valvular
abnormality (31). However, the negative relation between
body mass index and AR persisted in analyses excluding
individuals with specific causes of AR. Whatever the patho-
physiologic mechanism, the present findings conclusively
exclude a positive association between being overweight and
AR. As a result, the apparent excess of AR in some (10–14)
Figure 4. The prevalences of both mild (11) AR (solid bars) and more
severe ($21) AR (open bars) were higher (p , 0.01) in individuals with
thickened aortic valve cusps versus cusps of normal thickness.
Table 3. Left Ventricular Geometry in Relation to Presence and Degree of AR*
No AR 11 AR >21 AR p Value†
LVID (cm) 5.0 6 0.5 5.1 6 0.6 5.3 6 0.6 , 0.001
PWT (cm) 0.86 6 0.10 0.88 6 0.11 0.89 6 0.10 0.003
IVS (cm) 0.93 6 0.13 0.95 6 0.13 0.96 6 0.12 0.002
RWT 0.35 6 0.05 0.35 6 0.06 0.34 6 0.05 0.237
LV mass (g) 157.4 6 39.7 169.0 6 43.5 182.1 6 47.5 , 0.001
LV mass index (g/m2) 82.9 6 18.9 91.7 6 23.2 98.0 6 23.3 , 0.001
LVM/fat-free mass (g/kg) 3.0 6 0.7 3.4 6 0.9 3.6 6 0.9 , 0.001
LV mass/height2.7 (g/m2.7) 41.4 6 10.4 45.5 6 12.9 49.3 6 13.0 , 0.001
*Excluding participants with $21 mitral regurgitation as a confounding cause of volume overload. †By analysis of variance. Data
are presented as the mean value 6 SD.
AR 5 aortic regurgitation; IVS 5 interventricular septal thickness; LV 5 left ventricular; LVID 5 left ventricular
end-diastolic diameter; PWT 5 posterior wall thickness; RWT 5 relative wall thickness.
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studies in groups of overweight patients who had taken
appetite-suppressant medications cannot be attributed to an
underlying association between being overweight and AR.
Of note, we also observed a negative association between
being overweight and mitral regurgitation in the SHS study
group (32).
Causes of AR. The present study provides the first
population-based information on the association between
several potential mechanisms of AR and the actual presence
of valvular regurgitation. In accordance with previous stud-
ies, a positive association was observed between aortic root
diameter and the presence and severity of AR (33–35). This
association may reflect the essential role of the aortic root in
supporting the aortic valve cusps, such that dilation of the
root may pull apart the moorings of the leaflets, especially at
the commissures, reduce the overlap between leaflets and
thereby promote regurgitation. Larger aortic size and the
presence of AS and MS, a marker of rheumatic valvular
disease, were all independently associated with AR in
regression analyses. In addition, we observed positive asso-
ciations between AR and aortic cusp calcification, a poten-
tial cause of suboptimal leaflet apposition, and between AR
and the bicuspid aortic valve. In addition to the potential
disadvantage, in terms of efficient valve function, with
having two rather than the usual three cusps, we have
previously identified an association between regurgitant
bicuspid aortic valves and aortic dilation (36).
Left ventricular effects of AR. Finally, the present study
provides the first population-based data on the impact of
AR of differing severity, demonstrated by standard Doppler
echocardiographic methods, on LV structure and function.
In accordance with standard concepts of the impact of
volume overloading on the LV, increasing degrees of AR
were associated with stepwise increases in LV chamber
dimension and wall thickness without a change in relative
wall thickness, resulting in rising prevalences of eccentric
LV hypertrophy. Left ventricular chamber function, as
measured by endocardial fractional shortening and the
end-systolic stress/volume index ratio, was slightly reduced
in the presence of AR, but myocardial function, as assessed
by LV mid-wall shortening and stress-corrected mid-wall
shortening, was not systematically affected by AR. This
suggests that the decline in LV chamber function was
related to increased arterial pressure and, consequently,
end-systolic stress, which was not offset by a compensatory
increase in LV wall thickness.
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